Oncogenesis (journal)

From WikiMD's WELLNESSPEDIA

Oncogenesis is a scientific journal that covers research on all aspects of oncology, the study of cancer. It is published by the Nature Publishing Group. The journal publishes papers that provide significant and original contributions to the understanding of oncogenesis.

Overview[edit]

Oncogenesis is a peer-reviewed open access journal that publishes high-quality research in all areas of oncology. The journal aims to provide a platform for scientists and clinicians to publish their latest findings and to promote the exchange of ideas and information in the field of oncology. The journal covers a wide range of topics, including molecular biology, genetics, cell biology, biochemistry, and clinical research related to cancer.

The journal is published by the Nature Publishing Group, a division of Springer Nature, which is one of the world's leading global research, educational and professional publishers. The journal is part of the Nature Partner Journals series, which is a series of online-only, open access journals published in collaboration with world-renowned international partners.

Content[edit]

The content of Oncogenesis includes original research articles, review articles, and short communications. The journal encourages the submission of articles that report important advances in cancer research, including but not limited to:

  • The identification of novel oncogenes
  • The study of the molecular mechanisms of oncogenesis
  • The development of new therapeutic strategies for cancer
  • The investigation of the role of genetic and environmental factors in cancer development

Abstracting and indexing[edit]

Oncogenesis is abstracted and indexed in several databases, including PubMed Central, Scopus, and the Science Citation Index Expanded. According to the Journal Citation Reports, the journal has a 2019 impact factor of 5.112.

See also[edit]







Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.